At a glance
ClinicalIndex Comparison RecordN/ACompleted· 141 enrolled
Drug / intervention
Therapeutic hypothermia groupdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Anti-inflammatory Effect of Therapeutic Hypothermia in Out-hospital Cardiac Arrest Patients With Cardiogenic Shock Via Interleukin-6 Trans-signaling
In Brief
A clinical study evaluating Therapeutic hypothermia group for Cardiac Arrest. Completed, enrolled 141 participants across 1 site.
Detailed Summary
Acute myocardial infarction complicated with cardiogenic shock trigger IL-6, the strong inflammatory response, result in multiple organ failure, even death. While therapeutic hypothermia,to expect the possibility of anti-inflammatory effect via IL-6 bi-phasic effect and IL-10 , to improve the multiple organ failure, to increase survival rate and well cerebral performance.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Arrest
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartNov 2015
First PostedDec 2015
Primary CompletionAug 2018
TodayJul 2026
First PostedDec 17, 2015
Enrollment StartNov 1, 2015
Primary CompletionAug 18, 2018
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 10.5 years ago
Interventions
Therapeutic hypothermia groupdevice
Therapeutic hypothermia